Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05263778
Status:
UNKNOWN
Last Update Posted:
2022-03-03
First Post:
2022-02-14
Brief Title:
Cholesterol Lowering Via Bempedoic AcidEzetimibe an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Organization Data
Organization:
Kaiser Permanente
Class:
OTHER
Study ID:
1824539
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kaiser Permanente
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Esperion Therapeutics Inc | INDUSTRY |